Dendronized βCD Molecular Containers for Enhancing Drug Delivery

Researchers from Mexico 🇲🇽 investigated dendronized βCD molecular containers designed to improve cellular uptake while maintaining biocompatibility. In human astrocyte and glioblastoma cell models, these modified CDs ( βCD-modified with dimethylolpropionic acid (Bis-MPA) dendrons (βCD-m2G and βCD-m3G)) exhibited low cytotoxicity, entered cells efficiently, and altered lipid metabolism without inducing stress in smooth endoplasmic reticulum (SER) or disrupting normal astrocyte differentiation.  The uptake of the tested materials by the studied cell lines most likely occurs via simple diffusion, potentially through the formation of lipid inclusion bodies (LIBs), which facilitate the internalization of the molecular containers. The findings provide new insight into how functionalized CDs interact with brain cells and support their continued development as molecular carriers for drug delivery and other biomedical applications.

Diagram illustrating the effects of Mono-Dendronized beta-CD and Native beta-CD on SVGp12 and A172 cells, highlighting lipid inclusion body (LIB) formation, low cytotoxicity, improved cell differentiation, antioxidant effects, and increased mitochondrial number.

Neyra Citlali Cabrera-Quiñones, Elisa Roldán-Barreto, Rosalía Zúñiga-Castellanos, … et al., Patricia Guadarrama (2026) Biological responses of human astrocytes (SVGp12) and glioblastoma (A172) cells to dendronized β-cyclodextrin molecular containers: Morphological and molecular insights. Bioorganic Chemistry 180, 110194. https://doi.org/10.1016/j.bioorg.2026.110194.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.